Cayston

Product manufactured by Gilead Sciences, Inc.

Application Nr Approved Date Route Status External Links
NDA050814 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cayston ® Is Indicated To Improve Respiratory Symptoms In Cystic Fibrosis (Cf) Patients With Pseudomonas Aeruginosa . Safety And Effectiveness Have Not Been Established In Pediatric Patients Below The Age Of 7 Years, Patients With Fev 1 <25% Or >75% Predicted, Or Patients Colonized With Burkholderia Cepacia [See Clinical Studies (14) ]. To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Cayston And Other Antibacterial Drugs, Cayston Should Be Used Only To Treat Patients With Cf Known To Have Pseudomonas Aeruginosa In The Lungs. Cayston Is A Monobactam Antibacterial Indicated To Improve Respiratory Symptoms In Cystic Fibrosis (Cf) Patients With Pseudomonas Aeruginosa . Safety And Effectiveness Have Not Been Established In Pediatric Patients Below The Age Of 7 Years, Patients With Fev 1 <25% Or >75% Predicted, Or Patients Colonized With Burkholderia Cepacia . ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aztreonam AZTREONAM ZINC3830264

Comments